FDA Inspection
MGH Bone BankMGH Bone Bank – FDA Inspection, Mar 6, 2014
Record Details
This FDA Inspection record concerns MGH Bone Bank, with an inspection on March 6, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- MGH Bone Bank
- Inspection Date
- March 6, 2014
- Product Type
- Biologics
View Company Profile
ID · 9e155d14-0807-4904-82a3-30f460058383
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 870249
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.265(f)Return to inventory--procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MGH Bone Bank
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 2, 2022 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 24, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for MGH Bone Bank
- FDA Inspection 1165234 - 2022-03-02
- FDA Inspection 1000064 - 2017-01-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.